© Reuters. FILE PHOTO: Healthcare employees obtain the Moderna COVID-19 vaccine
BRUSSELS (Reuters) – The European Fee will shortly approve to be used the COVID-19 vaccine developed by U.S. firm Moderna (NASDAQ:), the bloc’s prime well being official mentioned after the European Medicines Company (EMA) accepted the drug on Wednesday.
“With EMA approval of the Moderna vaccine, we’re nearer to our purpose of getting a portfolio of secure and efficient COVID-19 vaccines. EU Fee authorisation will observe shortly,” EU well being Commissioner Stella Kyriakides mentioned in a tweet.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or injury on account of reliance on the data together with knowledge, quotes, charts and purchase/promote alerts contained inside this web site. Please be totally knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is among the riskiest funding kinds attainable.